French biotech Pharnext has seen the value of its shares collapse after it revealed that its lead drug, a treatment for Charcot-Marie ... the overall neuropathy limitation scale (ONLS), which ...
aDepartment of Medicine, Hospital de Apoyo Chepén, Chepén, Peru bDepartment of Family Medicine, Hospital de Apoyo Chepén, Chepén, Peru cDepartment of Internal Medicine, Hospital de Apoyo Chepén, ...
Six patients who presented with acute sensory neuropathy were studied. All patients underwent detailed clinical assessment along with electrophysiological tests and relevant laboratory investigations.
It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果